Synergistic anti-osteosarcoma cell effects of the methotrex-ate/PI3K/mTOR inhibitor nanoparticle codelivery system-Reference-Cited by-同舟云学术

Synergistic anti-osteosarcoma cell effects of the methotrex-ate/PI3K/mTOR inhibitor nanoparticle codelivery system

Published:2024-06-05 Issue:1 Volume:39 Page:
ISSN:1066-7857
Container-title:Materials Technology
language:en
Short-container-title:Materials Technology

Author:

Wang Menglan¹²,Li Lewei¹²,Zhong Wu¹²,Liu Zheda¹²,Fan Zehui¹²,Fu Shiyang¹²,Tao Xiaojun¹²,He Yanjuan¹,He Chunlian¹²^ORCID

Affiliation:

1. School of Medicine (WML, LLW, ZW, LZD, FZH, FSY, TXJ, HCL), Affiliated Fourth Hospital of Changsha (HYJ), Hunan Normal University, Changsha, Hunan, China

2. Key Laboratory of Study and Discovery of Small Targeted Molecules of Hunan Province, School of Medicine, Hunan Normal University, Changsha, Hunan, China

Funder

the Changsha Natural Science Foundation

Hunan Provincial Education Department Teaching Reform Project

Hunan Normal University School of Medicine Open Fund

Hunan University Student Innovation Project

General Project of Changsha Science and Technology Bureau

Publisher

Informa UK Limited

Link

https://www.tandfonline.com/doi/pdf/10.1080/10667857.2024.2362572

Reference36 articles.

1. Nanoengineered chitosan functionalized titanium dioxide biohybrids for bacterial infections and cancer therapy

2. Immunotherapy for osteosarcoma: Fundamental mechanism, rationale, and recent breakthroughs

3. Overview of Dual-Acting Drug Methotrexate in Different Neurological Diseases, Autoimmune Pathologies and Cancers

4. Delayed High-dose Methotrexate Excretion and Influencing Factors in Osteosarcoma Patients

5. Upregulation of micro-ribonucleic acid-128 cooperating with downregulation of PTEN confers metastatic potential and unfavorable prognosis in patients with primary osteosarcoma